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A B S T R A C T
Mutations in IFNGR1, IFNGR2, IL12RB1, IL12B, STAT1 and NEMO result in a common clinical phenotype
known as Mendelian Susceptibility to Mycobacterial Diseases (MSMD). Interleukin-12 receptor b1 (IL-
12Rb1) deﬁciency is the most common genetic etiology for MSMD. Known mutations affecting IL12RB1
are recessively inherited and are associatedwith null response to both IL-12 and IL-23. Mutation IL12RB1
1623_1624delinsTT was originally described in 5 families from European origin (2 from Germany; 1
from Cyprus, France and Belgium). Interestingly, this samemutation was found in an unexpectedly high
prevalence among IL-12Rb1 deﬁcient patients in Argentina: 5-out-of-6 individuals born to unrelated
families carried this particular change. To determinewhethermutation 1623_1624delinsTT represents a
DNA mutational hotspot or a founder effect, 34 polymorphic markers internal or proximal to IL12RB1
were studied in the Argentinean and the Belgian patients. A common haplotype spanning 1.45–3.51 Mb
was shared by all chromosomes carrying mutation 1623_1624delinsTT, and was not detected on 100
control chromosomes. Applying amodiﬁed likelihood-basedmethod the age of themost recent common
ancestor carryingmutation 1623_1624delinsTTwas estimated in 475 years (95% CI, 175–1275), which is
the time when the Spaniards initiated the colonization of the Americas. Mutation 1623_1624delinsTT
represents the ﬁrst founder effect described on IL-12Rb1, the most frequently affected gene in MSMD,
and affecting patients with European ancestors. The reason(s) behind the persistency of this mutation
acrossmultiple generations, its relative high prevalence, and any potential selective advantage are yet to
be established.
Published by Elsevier B.V.
Contents lists available at ScienceDirect
Infection, Genetics and Evolution
journa l homepage: www.e lsev ier .com/ locate /meegid1. Introduction
With more than 100 affected patients worldwide, IL-12Rb1
deﬁciency is the most common genetic etiology for Mendelian
susceptibility to Mycobacterial Disease (MSMD). Interleukin-12
receptorb1 deﬁciency causes an illness characterized by a selective
susceptibility to poorly pathogenic mycobacteria, and nontyphoid
Salmonella species attesting to the importance of IL-12R in the host
defense against intracellular pathogens (Altare et al., 1998; de Jong
et al., 1998; Fieschi et al., 2003; van de Vosse and Ottenhoff, 2006;
Filipe-Santos et al., 2006; Rosenzweig et al., 2006).* Corresponding author at: Servicio de Inmunologı´a, Hospital Nacional de
Pediatrı´a J. P. Garrahan, Combate de los Pozos 1881, Cdad. de Buenos Aires (1245),
Argentina. Tel.: +54 9 11 5408 2641; fax: +54 11 4308 4076.
E-mail address: srosenzweig@garrahan.gov.ar (S.D. Rosenzweig).
1567-1348/$ – see front matter . Published by Elsevier B.V.
doi:10.1016/j.meegid.2009.02.010Mutations on the IL12RB1 gene are associated with impaired
response to IL-12 and IL-23 (Altare et al., 1998; de Jong et al., 1998;
Hoeve et al., 2003).With only one exception, all IL-12Rb1 deﬁcient
patients described displayed no detectable IL-12Rb1 on their cell
surface due to mutations that either interrupt the open reading
frame (nonsense and frameshift mutations) or disrupt folding of
the protein (missense mutations) (Altare et al., 1998; de Jong et al.,
1998; Fieschi et al., 2003; Fieschi et al., 2004; van de Vosse and
Ottenhoff, 2006; Filipe-Santos et al., 2006). Complex mutation
1623_1624delinsTT (GC deletion, TT insertion) results in a silent
point mutation (V541 V) and the generation of a stop codon
(Q542X) in IL12RB. This particular change had been previously
described in 5 families fromEuropean origin (2 fromGermany; and
1 from Cyprus, France and Belgium) (Fieschi et al., 2003; Haerynck
et al., 2008). Unexpectedly, mutation 1623_1624delinsTT was
found in 5-out-of-6 Argentinean IL-12Rb1 deﬁcient patients (3
homozygous and 2 heterozygous) from 6 unrelated families.
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patients from different regions in the planet suggested that
recurrent mutations could arise (mutational hot spot). Alterna-
tively, it was possible that despite the geographic separation the
families shared a common ancestry (mutational founder effect).
Herein, these two alternative hypotheses are explored.
2. Patients, materials and methods
2.1. Patient cohort
Six patients with complete IL-12Rb1 deﬁciency and born to 6
unrelated non-consanguineous Argentinean families were
referred to the Hospital Nacional de Pediatrı´a J. P. Garrahan in
Buenos Aires, Argentina and evaluated for this study. All the
patients had been assessed for IFNg/IL-12/IL-23 pathway
integrity after they developed disseminated mycobacterial
infections early on life. All the patients developed disseminated
M. bovis—BCG infection after routine BCG vaccination. None of the
patients expressed IL-12Rb1 on the surface of their T cells or NK
cells as determined by ﬂow cytometry and their lymphocytes did
not respond to IL-12 stimulation ex vivo. All the patients were
screened for mutations on IL-12Rb1 by PCR ampliﬁcation of
genomic DNA (17 exons and exon/intron boundaries), followed by
direct sequencing of the PCR products. Among this cohort,
mutation 1623_1624delinsTTwas found in 5 affected individuals,
all of them born to European ancestors. Three patients were
homozygous and 2 heterozygous for this trait. Another patient,
Belgium-born and heterozygous for the same mutation, was also
included in this study.
The patients’ ancestry was established by direct questioning for
at least 4 generations in each affected family with no evidence of
consanguinity. However, encrypted relatedness could not be ruled
out completely.
Thirty-four polymorphic sites on chromosome 19 were
analyzed in these patients: 21 intragenic IL12RB1 (15 exonic, 6
intronic) and 13 extrageneic. All markers were tested on gDNA. In
addition, IL-12Rb1 mRNA was extracted, cDNA converted, PCR
ampliﬁed, subcloned and sequenced in heterozygous patients for
individual-allele IL12RB1-exonic polymorphic markers determina-
tion.
Genomic DNA was obtained by saline extraction from PBMCs.
Single nucleotide polymorphisms’ genotypingwas performedwith
DYEnamic ET Terminator Cycle Sequencing Kit (Amersham
Biosciences, Little Chalfont Buckinghamshire, UK) from PCR
products obtained using speciﬁc primers (Appendix) and Taq
polymerase (Invitrogen, Carlsbad, CA). Messenger RNA was
extracted from PBMCs of 1623_1624delinsTT heterozygous
patients according to the manufacturer’s instructions (Trizol,
Invitrogen, Invitrogen, Carlsbad, CA). Messenger RNA was reverse
transcribed to cDNA using Oligo-dT (Invitrogen, Carlsbad, CA) and
reverse transcriptase (Invitrogen, Carlsbad, CA) following produ-
cers’ protocols. Interleukin-12 receptor b1 cDNA was ampliﬁed
with Taq polymerase and speciﬁc primers. The obtained PCR
product was cloned into a TOPO TA vector (TOPO TA Cloning kit,
Invitrogen, Carlsbad, CA) and later used to transform TOP10 One
Shot Chemically Competent cells (Invitrogen, Carlsbad, CA).
Transformed bacteria were seeded on Luria Bertani (LB)-XGal-
Ampicillin (Amp) plates, efﬁciently-transformed bacteria were
grown in LB-Amp media, plasmidic DNA was extracted (Wizard
Plus SV Minipreps, Promega, Madison, WI), sequenced on an ABI
PRISM 3130 Genetic Analyzer, and analyzed using Gene Scan
software (Applied Biosystem). Microsatellites were PCR-ampliﬁed
with ﬂuorescent-labeled speciﬁc F primers, run on an ABI PRISM
3130 Genetic Analyzer, and analyzed using the Gene Scan
software.2.2. Control population
Genomic DNA was extracted from 50 unrelated healthy
Argentinean blood donors of European-descent (100 chromo-
somes). Samples were screened for SNPs G451C and A705G by
restriction fragment length polymorphism (RFLP) analysis and/or
direct sequencing. For SNP A705G allele frequency determination,
exon 7 IL12RB1 was PCR-ampliﬁed with speciﬁc primers, the
obtained product was PvuII-digested according to manufacturer’s
recommendations (New England Biolabs, Ipswish, MA), resolved in
2% agarose gels, stained with ethidium bromide and analyzed
under UV light. Digestion with PvuII in the presence of allele A705
generates 2 fragments of 107 and 91 bp and ruled out the presence
of the mutated haplotype. For G451C allele frequency determina-
tion, exon 4 IL12Rb1 was PCR-ampliﬁed with speciﬁc primers, the
obtained product was digestedwith restriction enzyme HphI (New
England Biolabs, Ipswish, MA), PAGE resolved in NOVEX 20% TBE
gels (Invitrogen, Carlsbad, CA), stained with ethidium bromide and
analyzed under UV light. Digestion with HphI generates a set of
four fragments (320, 172, 112 and 36 bp) in the presence of allele
451C, while a different set of fragments (284, 226, 94 and 36 bp) is
observed in the presence of allele G451. Homozygosity for G451
ruled out the presence of the mutated haplotype. Six normal
controls (12 chromosomes)were tested by direct sequencing of the
entire coding region of IL12Rb1 gene.
All patients and controls gave written consent for DNA/RNA
extraction and analysis. Primer sequences are shown in the
Appendix A, Table A1.
2.3. Mutation 1623_1624delinsTT age estimation
In order to estimate the age to the most recent common
ancestor of haplotypes carrying the 1623_1624delinsTT mutation,
a previously described likelihood method was modiﬁed and
applied on a set of six recombination markers located at variant
distances on both sides of the diseasemutation (Genin et al., 2004).
The approximation was introduced by Genin and collaborators as
an interval censored survival analysis in which themutation locus,
denoted as D, is the starting point, the genetic distance is the time
scale and the occurrence of recombination is the event. The model
takes the following basic assumptions:
 monophyletic origin of the disease mutation
 independence of each sampled chromosome and equal time to a
common ancestor
 independent recombination rates at each side of D
 negligible probability of double recombination
GivenM1,. . .,Mx,. . .,Mk k orderedmarkers typed on one side ofD,
let u1,. . .,ux,. . .,uk be the recombination fractions from D (for
convenience, u0 = 0 and uk + 1 = 1). Deﬁne S(x), the probability that
no recombination took place during n generations between D and
Mx as
SðxÞ ¼ ð1 uxÞn:
Therefore, the probability of recombination in the xth interval—
between Mx  1 and Mx—namely f(x), is
f ðxÞ ¼ Sðx 1Þ  SðxÞ:
Taking advantage of this construction, missing information on
Mx  1 for any sampled chromosome could be handled by
considering the most distant marker from D without recombina-
tion (Mx  2, Mx  3, etc). However, as the intervals include more
missing markers the assumption of negligible double recombina-
tion becomes less sustainable, and further formulations would be
needed. Under the described model, the likelihood function is
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chromosomes two situations should be noticed. In the ﬁrst one,
every chromosome shows evidence of recombination to one side of
D. In this case, there are two groups of haplotypes. In one group,
denoted as G1, y chromosomes (2  y  N) share all their alleles for
markers M1,. . .Mk1 and have a different allele at Mk. For the G1
group, the likelihood is written
LG1ðnÞ ¼ f ðkÞy þ ySðkÞ f ðkÞy1; (1)
taking into account the uncertainty onwhich the ancestral allele is.
In the remaining N  y chromosomes, G2, a recombination
occurred on the interval xi (1  i  N  y) closer to D (xi  k). For
G2 the likelihood is written
LG2ðnÞ ¼
Y
i2G2
f ðxiÞ: (2)
A less desirable, unless possible, scenario is foundwhen there is
no recombination before Mk. In other words, a set of z
chromosomes, group G3, present the same alleles for M1 to Mk.
Accordingly, likelihood is
LG3ðnÞ ¼ SðkÞz: (3)
Note that when the G3 group is not empty then G1 is. Finally,
chromosomes with missing data for markers Ma,. . .,Mk (1  a  k)
and without evidence of recombination for markers M1,. . .,Ma  1
conform G4, with likelihood
LG4ðnÞ ¼
Y
j2G4
Sðx jÞ; (4)
where xj < k is the interval to the last marker with available
information and no recombination.
In conclusion, the likelihood for n generations on the studied
side is
LsideðnÞ ¼ ½IG1 6¼?LG1 ðnÞ þ IG3 6¼?LG3 ðnÞ þ ð1 IG1 6¼?
 IG3 6¼? ÞLG2 ðnÞLG4 ðnÞ; (5)
where IGa 6¼? equals 0 if group a is empty and 1 if it is not. The ﬁnal
likelihood, L(n), is the product of the two side likelihoods. Point
estimation of generation number n is obtained at L(n) maximum.
Equations (1)–(5) hold without ambiguity if the presence or
absence of a recombination event within intervals is known.
However, they do not account for mutation, resulting in a false
positive recombination signal, or low allele diversity, resulting in a
false negative recombination signal. The adjustments introduced
to deal with this ambiguity are described in the Appendix. Further
calculation for 1623_1624delinsTT included both corrections.
Computation of 95% conﬁdence intervals (CI) for an estimated
generation number was based on Bayesian principles. Brieﬂy, 95%
CI is given by all n which satisﬁes:
0:025 
Pn
u¼1LðuÞPV
v¼1LðvÞ
 0:975;
where V is a large generation number (e.g. 104).
Algorithms were programmed on R version 2.6.0, a free
software environment. Scripts are available upon request. Like-
lihood corrections for mutation and allele frequency calculation
are described in the Appendix.
2.4. Extragenic markers recombination fraction estimation
The preceding theory is based on a priori knowledge on
recombination fractions u1,. . .,uk. Thereafter, recombination rates
for the intervals among the selectedextragenicmarkersatboth sides
of 1623_1624 delGCinsTT were estimated by means of a robustlinear regression, carried outwith published data on 37neighboring
polymorphic sites incorporated into the Marshﬁeld linkage map
(Fig. 2). Linkage (Kosambi centiMorgans, cM) was inferred for
D19S1037, CRLF1, D19S895, SFRS14, TSSK6 and D19S215 based on
sequence position on chromosome 19 (mega base pairs, Mb).
Calculated fractions are presented in Table 1. The result represents
an average of 1.16 cM per Mb across the entire region.
3. Results
3.1. Mutation 1623_1624delinsTT haplotyping
All patients carrying mutation 1623_1624delinsTT in homo-
zygous or heterozygous state shared a common haplotype on the
mutated allele of chromosome 19, which included the complete
IL12RB1 gene (Table 1). Thirty-four polymorphic sites on chromo-
some 19 were analyzed: 21 intragenic IL12RB1 (15 exonic, 6
intronic) and 13 extrageneic. Of the 34 markers analyzed, 32 were
included on the mutated haplotype (from C72A to TSSK6:T989C;
distance between markers, 1.45 Mb). Markers D19S1037 and
D19S215, which showed variations in homozygous and hetero-
zygous patients, ﬂanked and deﬁned the mutated haplotype
(distance between markers, 3.51 Mb).
None of the 100 control chromosomes analyzed carried the
mutated haplotype above described. Control chromosomes were
screened for SNPs G451C and A705G (variants 451C and 705G on
the mutated allele) by restriction fragments length polymorphism
(RFLP) analysis (Fig. 1). Eighty-eight percent of the tested samples
were excluded as carrying the mutated haplotype by this method;
the remaining 12% were ruled out by IL12RB1 gDNA direct
sequencing. Since the mutated haplotype was not found in any of
the 100 control chromosomes tested, its frequency remains0.01%
in the general population. Therefore, the probability that mutation
1623_1624delinsTT have occurred by chance sharing the same set
of polymorphic markers in the 9 affected alleles is not larger than
the probability of randomly sampling nine times in a row the
mutated haplotype, namely (0.01)9 = 1018. Together these data
strongly suggested that the 1623_1624delinsTT mutated allele
originated from a single founder.
3.2. Mutation 1623_1624delinsTT age calculation
The most likely age for mutation 1623_1624delinsTT was 19
generations,witha95%Conﬁdence Interval (CI)of7–51.Considering
25 years for each generation, this represents 475 years (95%CI, 175–
1275) (Fig. 2). Estimation of themutation agewas calculated from6
extragenic recombination markers applying a modiﬁed likelihood-
method based on that originally described by Genin et al., 2004.
Variations on microsatellites D19S1037, D19S895, and D19S215,
and10SNPsdistributedalonggenesCRLF1 (3SNPs), SFRS14 (5SNPs)
and TSSK6 (2 SNPs) were tested. The 10 SNPs were considered as 3
independent loci—one for each gene—assuming null recombination
frequencieswithineachgene.Mutations rates andallele frequencies
were taken into account according to previous reports (Weber and
Wong, 1993; Nachman and Crowell, 2000). Mutation rates were set
to 5.6 104, 2.1 103 and 2.55 108 for dinucleotide tandem
repeats, tetranucleotide tandem repeats, and SNPs, respectively, as
shown in Section 2.
To assess the contribution of the assumed mutation frequencies
to the estimated timeof the foundermutation, the samecalculations
were carried out for varying mutation rates. Assumption that the
rate of mutations was one order (10 times) higher resulted in an
estimation of 12 generations (95% CI, 4–30), while if the rate was
assumed to be one order lower, the estimated mutation age would
be 21 generations (95% CI, 7–55). Of note, these modiﬁcations
yielded a projected outcome encompassed by the initial conﬁdence
Table 1
Mutation 1623_1624delinsTT haplotyping.
Single allele nomenclature is used for homozygous SNPs, while both alleles are shown for heterozygous SNPs. Single repeat numbers denote homozygous microsatellite repeats, while both repeats are shown for
heterozygous ones. Black-shaded: mutation 1623_1624delinsTT. Gray-shaded: distal markers deﬁning and ﬂanking the mutated haplotype. PD, Physical Distance to IL12RB1 expressed in mega-bases (Mb); AF, Allelic
Frequency; RF, Recombination Frequency; P1–P6, Patients 1–6; ND, Not Done; im, IL12RB1 intragenic marker (null recombination was assumed); Homoz., Homozygous for mutation 1623_1624delinsTT; Heteroz.,
Heterozygous for mutation 1623_1624delinsTT; IL12RB1 ex., IL12RB1 exonic; IL12RB1 int., IL12RB1 intronic.
J.
Y
a
n
co
sk
i
et
a
l./In
fectio
n
,
G
en
etics
a
n
d
E
v
o
lu
tio
n
9
(2
0
0
9
)
5
7
4
–
5
8
0
5
7
7
Fig. 1. Mutated haplotype screening on control chromosomes. (A) Gel electrophoresis of PvuII-digested exon 7 IL12RB1. The 3 digestion patterns found in the Control
population are shown. A705 homozygosity (A/A*) ruled out themutated haplotype. (B) Gel electrophoresis of HphI-digested exon 4 IL12RB1. The 2 possible digestion patterns
found in the Control population are shown. G451 homozygosity (G/G*) ruled out the mutated haplotype.
Fig. 2. Extragenic markers recombination fraction estimation. Known distances and
linkage for polymorphic sites surrounding IL12RB1 locus (ﬁlled rhombi) are shown.
Linkage estimation for the extragenic markers indicated on the graph was based on
a robust regressionmethod. The slope derived from the least squaresmethod is also
despicted, although it shows a poorer ﬁt and a slight bias due to outlying
observations.
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arbitrarily set to 1/7 (1/n8 of described alleles), only had a slight
inﬂuence on inference. Speciﬁcally, for an allele frequency of 0.5, the
estimationwouldcorrespond to20generations (95%CI, 7–52),while
if D19S1037 allele frequency contributionwere set to 0, the inferred
number of generations was 19, same as initial calculations (95% CI,
7–50). A basic model assumption for the derived estimations was a
phylogeny with star topology (i.e., equal distance to a common
ancestor) and so haplotype relatedness would bias computed
generation numbers. In an attempt to assess this assumption, age to
origin was evaluated for 9 sub-samples, sequentially dropping one
chromosome at the time. All estimations rounded the initial
calculation of 19 generations with a range of 13 generations (95%
CI, 3–40) to 22 generations (95% CI, 8–60). This relatively small
variation suggests that this assumption is valid, though relatedness
among some inherited haplotypes cannot be ruled out. In
conclusion, the estimation of 19 generations (7–51 with a 95%
conﬁdence) to a common origin for the 1623_1624delinsTT
mutation appeared robust.
4. Discussion
In the IL12RB1 gene mutation database (http://153.1.44.13/
IL12RB1base/), 24 differentmutations affecting 50 individuals from
38 unrelated families are summarized. Mutation
1623_1624delinsTT is described in 7 individuals (5 homozygous
and2heterozygous) from4different families previously reportedby
Fieschi et al. (2003). This same mutation is even more prevalent
among Argentinean IL-12Rb1 deﬁcient patients: 8-out-of-12
affected alleles (almost 67%) bear mutation 1623_1624delinsTT.
Noteworthy, although all the Argentinean IL-12Rb1 deﬁcient
patients, as well as the Belgian patient studied, belonged to families
with European ancestry, their families did not appear to be related.
When identical mutations are detected in apparently unrelated
patients, it is important to discriminatewhether they have aroused
by recurrent mutations (mutational hot spot) or they are identical
by descent (mutational founder effect). In this case, the absence of
direct repeats, palindromes/quasi-palindromes, polypurine runs,
polypyrimidine runs or consensus motifs typically associated with
different types of mutational hotspots in the surrounding area
argued against a putative mutational hotspot (Krawczak and
Cooper, 1993). On the other hand, the detection of a common
haplotype spanning 1.45 (distance between C72A and TSSK:T989C,
distal markers common to all affected alleles) to 3.51 Mb (distance
between D19S1037 and D19S215, ﬁrst markers to show differ-
ences on the affected alleles), strongly supports the mutational
founder effect hypothesis.
Many Mendelian disorders demonstrate mutations that can be
traced to a founder whose existence can be inferred from the
unique chromosomal background onwhich themutation occurred(Zeegers et al., 2004). Founder mutations have been described for
several primary immunodeﬁciencies, including those conferring
MSMD. Mutation g.482 + 82_856–854 (a large loss-of-function
deletion) and g.315_316insA (a frameshift insertion) in IL12B (IL-
12p40) are founder mutations associated to increased suscept-
ibility to mycobacteria and salmonella infections arising 700 and
1100 years ago, respectively (Picard et al., 2002; Li et al., 2002;
Campbell et al., 2003; Sanchez et al., 2007). In the case of IL-12Rb1
deﬁciency due to mutation 1623_1624delinsTT, the founder effect
was estimated to occur 475 years ago (95% CI, 175–1275). To
determine so, a slightly modiﬁed likelihood method from that
originally described by Genin et al. (2004) was applied. The
introduced modiﬁcations used different parameters to better
adjust the intrinsic bias on mutation age-estimation inherent to
this type of calculations.
It is noteworthy, that the city of Buenos Aires was funded by
Pedro de Mendoza in 1536, approximately at the same time as the
estimated arousal ofmutation 1623_1624delinsTT. It is tempting to
speculate that mutation 1623_1624delinsTT was introduced into
thecountry in themid-16thcenturybytheSpanishcolonization.The
current Argentinean population has a genetically heterogeneous
ethnic background mainly conferred by waves of European
immigrants and their integration to a sparse native population.
Following the colonization by the Spaniards in themid-16th century
there was a signiﬁcant decrease (‘‘bottlenecks’’) on the native
population associated with massive killings and transmitted
Table A1
Primers.
Intragenic markers
SNP Sequence (50 ! 30)
C72A (exon 1) Forward ctc agc ttc aat gtg ttc cgg
Reverse aca cat aca cgt gcc tcc ac
C202T (exon 3) Forward ttg tct tag gca cga aga cc
Reverse gat cac gca tcc gag agt ag
G451C (exon 4) Forward atg cac aaa gtc ggc tgt gg
Reverse gga atc ctc tct agc tcc ag
G531A (exon 5) Forward agt tgc tta ccc tgg aca gg
Reverse gga cag atg cag aga tgg tg
A705G (exon 7) Forward aga gtg aga ccg tgt ctc ag
C748T (exon 7) Reverse gct gga act aca ggt gtg ca
C1081A (exon 9) Forward gtc tgt ctt cat agg ctg tg
Reverse cac ccc taa atc agg cac tc
T1158C (exon 10) Forward gga gag aga tgg caa ctg tc
G1196C (exon 10) Reverse acc cac cag gac cta aaa gg
C1213T (exon 10)
C1306T (exon 11) Forward agt agg agt ttt ctg ggg gt
C1376T (exon 11) Reverse aga cag ggt ttc gcc aca tt
G1637A (exon 13) Forward gat cat tgt ggg aag cgc ag
Reverse ggc ctc tga gga gta aag ag
C1783T (exon 15) Forward aca gag caa gac tcc gtc tc
G1845C (exon 15) Reverse atg cgt aac cct tgt cca gc
Extragenic markers
Amplicon Sequence (50 ! 30)
D19S1037 Forward ctg cggagt cag aaa aca gt
Reverse atg cag cta tcc ctc att ca
CRLF1 (exon 2) Forward cca act tac ggc caa cat ag
Reverse aca atc att aac agc gtc ttt t
D19S895 Forward ttg cag taa cca tgc cac
Reverse cca gga cac ttt tgc tag tca c
SFRS14 (exon 3) Forward aac ttt ggc tga ttt cct tac c
Reverse tcc agg ctg att gag aaa gag t
TSSK6 (exon 1) Forward cct ggc gga cgg gct gaa ctg
Reverse gcg cca tgg ctt aga ccc gag att
D19S215 Forward cat gca tta aaa atg aca act gt
Reverse gct ctg can tcc att act ca
J. Yancoski et al. / Infection, Genetics and Evolution 9 (2009) 574–580 579diseases (Sanchez et al., 2007; Martı´nez Marignac et al., 2004;
Mulligan et al., 2004; Alfaro et al., 2005; Resano et al., 2007). While
mating between the European colonizers and the natives helped to
spread the mutation, the reduction on the local population
contributed to the mutation enrichment of the genetic pool.
In summary, herein we present strong evidence to support that
mutation IL12RB1 1623_1624delinsTT, a rare genomic change, is
inherited as a haplotypeblockwith a common founder arousing 475
years ago (95% CI, 175–1275). This ﬁnding represents the ﬁrst
founder effect described on the IL-12/23 receptor complex, critical
for controlling mycobacterial as well as salmonella infections, and
affecting patients with European ancestry. The reason(s) behind the
persistencyof thismutationacrossmultiplegenerations, orwhether
it confers any kind of selective advantage, has yet to be established.
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Appendix A. Appendix
A.1. Likelihood correction for mutation
Beside recombination, haplotype differences can also be explained
by mutation. Some formulations from Genin et al. (2004) were
applied to account for this ambiguity. Assuming known mutation
rates, m1,. . .,mx,. . .,mk (for M1,. . .,Mx,. . .,Mk, respectively), the prob-
ability that during n generations no marker mutation has occurred
from D up to Mx, denoted U(x), is
UðxÞ ¼
Yx
w¼1
ð1mhÞn
and the probability of mutation at marker Mx over n generations,
u(x), has the expression
uðxÞ ¼ 1 ð1mxÞn:
Thus, the likelihood contribution for a chromosome iwhich shares
an ancestral haplotype until marker Mx  1 and has different allele
at marker Mx is
hðxÞ ¼ Uðxi  1Þ½ f ðxiÞ þmxi SðxiÞ;
which contemplates the possibilities that either a recombination
occurred betweenmarkersMx  1 andMx or no recombination took
place up to marker Mx but a mutation event did happen at Mx.
Lastly, to account for mutation in the likelihood formulations, the
following corrections were applied to equations (1)–(4) in the main
text:
LmutG1 ðnÞ ¼ hðkÞ
y þ yUðkÞSðkÞhðkÞy1
LmutG2 ðnÞ ¼
Y
i2G2
hðxiÞ
LmutG3 ðnÞ ¼ ½UðkÞSðkÞ
z
LmutG4 ðnÞ ¼
Y
j2G4
Uðx jÞSðx jÞ
A.2. Likelihood correction for allele frequency
When polymorphisms of markers are low, an event of recombina-
tion with the same allele becomes more plausible. Thereafter, toaccount for hindered crossing-over, a modiﬁcation to the second
order approximation suggested in Genin et al. (2004) was imple-
mented.
Let px be the frequency of the allele present on the ancestral
haplotype at the Mx locus. Considering only the possibility of two
unnoticed events of recombination, expressions (1)–(4) become:
LalleleðnÞ ¼ f ðkÞy þ y pk1 f ðk 1Þ f kð Þy1
þ y
2
 
p2 f ðk 1Þ2 f ðkÞy2 þ y pk1 pk2 f ðk 2Þ f ðkÞy1
þ yðy 1Þp2 pk2 f ðk 2Þ f ðk 1Þ f ðkÞ þ ySðkÞ f ðkÞy1
þ yðy 1ÞSðkÞpk1 f ðk 1Þ f ðkÞy2
þ y y 1
2
 
p2SðkÞ f ðk 1Þ2 f ðkÞy3 þ yðy
 1Þ pk1 pk2SðkÞ f ðk 2Þ f ðkÞy2 þ yðy 1Þðy
 2Þ p2 pk2SðkÞ f ðk 2Þ f ðk 1Þ f ðkÞ
- The term with coefﬁcient
y 1
2
 
is only computed if y > 2.
LalleleðnÞ ¼
Y
i2G2
½ f ðxiÞ þ pxi1 f ðxi  1Þ þ pxi1 pxi2 f ðxi  2Þ;
LalleleðnÞ ¼ ½SðkÞ þ pk f ðkÞ þ pk pk1 f ðk 1Þz;
LalleleðnÞ ¼
Y
j2G4
½Sðx jÞ þ pxj f ðx jÞ þ pxj1 pxj f ðx j  1Þ:
J. Yancoski et al. / Infection, Genetics and Evolution 9 (2009) 574–580580Note that the only difference to previous formulations from Genin
et al. (2004) are the terms for LG1(n) that contemplate recombination
on Mk  1 and Mk  2 on two independent events, namely
yðy 1Þp2 pk2 f ðk 2Þ f ðk 1Þ f ðkÞy2
and
yðy 1Þðy 2Þp2 pk2SðkÞ f ðy 2Þ f ðy 1Þ f ðkÞy3:
Following the same line of thought that derives in the original
expression, the extension includes the probabilities of observing
ancestral alleles atMk  1 andMk  2 after one recombination event on
the (k  2)th interval, pk  1pk  2(k  2), and one ancestral allele at
Mk1 after one recombination event on the (k  1)th interval,
pk1(k  1). The additional terms make a more signiﬁcant contribu-
tion to the ﬁnal likelihood as (y  1)pk1 increases and f(k)/f(k 1)
decreases.
References
Alfaro, E.L., Pierini, J.E., Gutierrez, N.I., Vullo, C.M., 2005. Genetic structure and
admixture in urban populations of the Argentine North-West. Ann. Hum. Biol.
32, 724–737.
Altare, F., Durandy, A., Lammas, D., Emile, J.F., Lamhamedi, S., Le Deist, F., Drysdale,
P., Jouanguy, E., Do¨fﬁnger, R., Bernaudin, F., Jeppsson, O., Gollob, J.A., Meinl, E.,
Segal, A.W., Fischer, A., Kumararatne, D., Casanova, J.L., 1998. Impairment of
mycobacterial immunity in human interleukin-12 receptor deﬁciency. Science
280, 1432–1435.
Campbell, C., Mitui, M., Eng, L., Coutinho, G., Thorstenson, Y., Gatti, R.A., 2003. ATM
mutations on distinct SNP and STR haplotypes in ataxia-telangiectasia patients
of differing ethnicities reveal ancestral founder effects. Hum. Mutat. 21, 80–85.
de Jong, R., Altare, F., Haagen, I.A., Elferink, D.G., Boer, T., van Breda Vriesman, P.J.,
Kabel, P.J., Draaisma, J.M., van Dissel, J.T., Kroon, F.P., Casanova, J.L., Ottenhoff,
T.H., 1998. Severe mycobacterial and Salmonella infections in interleukin-12
receptor–deﬁcient patients. Science 280, 1435–1438.
Fieschi, C., Dupuis, S., Catherinot, E., Feinberg, J., Bustamante, J., Breiman, A., Altare,
F., Baretto, R., Le Deist, F., Kayal, S., Koch, H., Richter, D., Brezina, M., Aksu, G.,
Wood, P., Al-Jumaah, S., Raspall, M., Da Silva Duarte, A.J., Tuerlinckx, D.,
Virelizier, J.L., Fischer, A., Enright, A., Bernho¨ft, J., Cleary, A.M., Vermylen, C.,
Rodriguez-Gallego, C., Davies, G., Blu¨tters-Sawatzki, R., Siegrist, C.A., Ehlayel,
M.S., Novelli, V., Haas, W.H., Levy, J., Freihorst, J., Al-Hajjar, S., Nadal, D., De
Moraes Vasconcelos, D., Jeppsson, O., Kutukculer, N., Frecerova, K., Caragol, I.,
Lammas, D., Kumararatne, D.S., Abel, L., Casanova, J.L., 2003. Low penetrance,
broad resistance, and favorable outcome of interleukin 12 receptor b1 deﬁ-
ciency, medical and immunological implications. J. Exp. Med. 197, 527–535.
Fieschi, C., Bosticardo, M., de Beaucoudrey, L., Boisson-Dupuis, S., Feinberg, J.,
Santos, O.F., Bustamante, J., Levy, J., Candotti, F., Casanova, J.L., 2004. A novel
form of complete IL-12/IL-23 receptor beta1 deﬁciency with cell surface–
expressed nonfunctional receptors. Blood 104, 2095–2101.Filipe-Santos, O., Bustamante, J., Chapgier, A., Vogt, G., de Beaucoudrey, L., Feinberg,
J., Jouanguy, E., Boisson-Dupuis, S., Fieschi, C., Picard, C., Casanova, J.L., 2006.
Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular,
cellular, and clinical features. Semin. Immunol. 18, 347–361.
Genin, E., Tullio-Pelet, A., Begeot, F., Lyonnet, S., Abel, L., 2004. Estimating the age of
rare disease mutations: the example of Triple-A syndrome. J. Med. Genet. 41,
445–449.
Haerynck, F., Holland, S.M., Rosenzweig, S.D., Casanova, J.L., Van daele, S., Schel-
straete, P., De Baets, F., 2008. DisseminatedMycobacterium avium infection in a
patientwith a novelmutation in the interleukin-12 receptorb1 chain. J. Pediatr.
153, 721–722.
Hoeve, M.A., de Boer, T., Langenberg, D.M.L., Sanal, O., Verreck, F.A.W., Ottenhoff,
T.H.M., 2003. IL-12 receptor deﬁciency revisited: IL-23-mediated signaling is
also impaired in human genetic IL-12 receptor b1 deﬁciency. Eur. J. Immunol.
33, 3393–3397.
Krawczak, M., Cooper, D.N., 1993. Human Gene Mutations. Bios Scientiﬁc Publish-
ers, Oxford.
Li, L., Moshous, D., Zhou, Y., Wang, J., Xie, G., Salido, E., Hu, D., de Villartay, J.P.,
Cowan, M.J., 2002. A foundermutation in Artemis, an SNM1-like protein, causes
SCID in Athabascan-speaking Native Americans. J. Immunol. 168, 6323–6329.
Martı´nez Marignac, V.L., Bertoni, B., Parra, E.J., Bianchi, N.O., 2004. Characterization
of admixture in an urban sample from Buenos Aires, Argentina, using unipar-
entally and biparentally inherited genetic markers. Hum. Biol. 76, 543–557.
Mulligan, C.J., Hunley, K., Cole, S., Long, J.C., 2004. Population genetics, history, and
health patterns in Native Americans. Annu. Rev. Genomics Hum. Genet. 5, 295–
315.
Nachman, M.W., Crowell, S.L., 2000. Estimate of the mutation rate per nucleotide in
humans. Genetics 156, 297–304.
Picard, C., Fieschi, C., Altare, F., Al-Jumaah, S., Al-Hajjar, S., Feinberg, J., Dupuis, S.,
Soudais, C., Al-Mohsen, I.Z., Ge´nin, E., Lammas, D., Kumararatne, D.S., Leclerc, T.,
Raﬁi, A., Frayha, H.,Murugasu, B.,Wah, L.B., Sinniah, R., Loubser,M., Okamoto, E.,
Al-Ghonaium, A., Tufenkeji, H., Abel, L., Casanova, J.L., 2002. Inherited inter-
leukin-12 deﬁciency: IL12B genotype and clinical phenotype of 13 patients
from six kindreds. Am. J. Hum. Genet. 70, 336–348.
Resano, M., Esteban, E., Gonza´lez-Pe´rez, E., Vı´a, M., Athanasiadis, G., Avena, S.,
Goicoechea, A., Bartomioli, M., Ferna´ndez, V., Cabrera, A., Dejean, C., Carnese, F.,
Moral, P., 2007. How many populations set foot through the Patagonian door?
Genetic composition of the current population of Bahı´a Blanca (Argentina)
based on data from 19 Alu polymorphisms. Am. J. Hum. Biol. 19, 835–877.
Rosenzweig, S.D., Yancoski, J., Bernasconi, A., Krasovec, S., Marciano, B.E., Casimir, L.,
Berberian, G., Simboli, N., Rousseau, M., Calle, G., 2006. Thirteen years of
culture-positive M. bovis-BCG infection in an IL-12Rbeta1 deﬁcient patient:
treatment and outcome. J. Infect. 52, e69–e72.
Sanchez, J.J., Monaghan, G., Børsting, C., Norbury, G., Morling, N., Gaspar, H.B., 2007.
Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA)
gene implies a high incidence of ADA-deﬁcient severe combined immunode-
ﬁciency (SCID) in Somalia and a single, common haplotype indicates common
ancestry. Ann. Hum. Genet. 71, 336–347.
van de Vosse, E., Ottenhoff, T.H., 2006. Human host genetic factors in mycobacterial
and Salmonella infection: lessons from single gene disorders in IL-12/IL-23-
dependent signaling that affect innate and adaptive immunity. Microbes Infect.
8, 1167–1173.
Weber, J.L., Wong, C., 1993. Mutation of human short tandem repeats. Hum. Mol.
Genet. 2, 1123–1128.
Zeegers, M.P., van Poppel, F., Vlietinck, R., Spruijt, L., Ostrer, H., 2004. Founder
mutations among the Dutch. Eur. J. Hum. Genet. 12, 591–600.
